Literature DB >> 29253429

Effectiveness of Canada's tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based retrospective cohort study.

Leyla Asadi1, Courtney Heffernan2, Dick Menzies3, Richard Long4.   

Abstract

BACKGROUND: In Canada, tuberculosis disproportionately affects the foreign-born population. The national tuberculosis medical surveillance programme aims to prevent these cases. Individuals referred for further in-country surveillance (referrals) have a history of active tuberculosis or have features of old, healed tuberculosis on chest radiograph; those not referred (non-referrals) do not undergo surveillance. We aimed to examine the risk of transmission arising from referrals versus non-referrals.
METHODS: We did this population-based retrospective cohort study of foreign-born migrants (aged 15-64 years) to Alberta, Canada, between Jan 1, 2002, and Dec 31, 2013. We obtained information about year of arrival and country of citizenship from Immigration, Refugees and Citizenship Canada, and data for tuberculosis cases and their contacts from the Alberta Tuberculosis Registry. The outcome of interest was culture-positive pulmonary tuberculosis. We compared the incidence of pulmonary tuberculosis and the odds of transmission among referrals versus non-referrals. By use of conventional and molecular epidemiological techniques, we defined transmission as either a secondary case or a tuberculin skin-test (TST) conversion among close contacts. We used multivariate logistic regression to determine the independent association between referral for tuberculosis surveillance and transmission.
FINDINGS: Between 2002 and 2013, there were 223 225 foreign-born migrants to Alberta, of whom 5500 (2%) were referrals and 217 657 (98%) were non-referrals. 3805 (69%) referrals and 115 226 (53%) non-referrals were from countries with a tuberculosis incidence of more than 150 per 100 000 populations, or sub-Saharan Africa. 234 foreign-born individuals were diagnosed with culture-positive pulmonary tuberculosis between Jan 1, 2004, and Dec 31, 2013. The incidence of culture-positive pulmonary disease was nine times higher in referrals (n=50) than all non-referrals (n=184; incidence rate ratio 9·1, 95% CI 6·7-12·5) and five times higher in referrals than non-referrals from high-risk countries (n=167; 5·0, 3·6-6·8). 71 total transmission events arose from the individuals with culture-positive pulmonary tuberculosis-three (4%) from referrals and 68 (96%) from non-referrals. No secondary cases were attributable to a referral source case, whereas 18 secondary cases were attributable to 11 different non-referral source cases. Three TST conversions were attributable to three different referral source cases compared with 50 conversions from 31 different non-referral source cases. That is, three (6%) referrals transmitted tuberculosis compared with 42 (22%) non-referrals (adjusted odds ratio of 0·19, 95% CI 0·054-0·66; p=0·009).
INTERPRETATION: Despite a much higher incidence of pulmonary tuberculosis in referrals than non-referrals, referrals were 80% less likely to transmit tuberculosis. Rather than a focus on referrals, Canada could consider screening and treatment of latent tuberculosis in all migrants from high-risk countries-a group that accounted for 100% of secondary cases. FUNDING: Canadian Institutes of Health Research.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29253429     DOI: 10.1016/S2468-2667(17)30161-5

Source DB:  PubMed          Journal:  Lancet Public Health


  8 in total

1.  Estimated Impact of World Health Organization Latent Tuberculosis Screening Guidelines in a Region With a Low Tuberculosis Incidence: Retrospective Cohort Study.

Authors:  Lisa A Ronald; Jonathon R Campbell; Caren Rose; Robert Balshaw; Kamila Romanowski; David Z Roth; Fawziah Marra; Kevin Schwartzman; Victoria J Cook; James C Johnston
Journal:  Clin Infect Dis       Date:  2019-11-27       Impact factor: 9.079

Review 2.  Tuberculosis among refugees and migrant populations: Systematic review.

Authors:  Abyot Meaza; Habteyes Hailu Tola; Kirubel Eshetu; Tedla Mindaye; Girmay Medhin; Balako Gumi
Journal:  PLoS One       Date:  2022-06-09       Impact factor: 3.752

Review 3.  Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK.

Authors:  Sally Hayward; Rosalind M Harding; Helen McShane; Rachel Tanner
Journal:  F1000Res       Date:  2018-04-13

4.  Is there a fundamental flaw in Canada's post-arrival immigrant surveillance system for tuberculosis?

Authors:  Richard Long; Leyla Asadi; Courtney Heffernan; James Barrie; Christopher Winter; Mary Lou Egedahl; Catherine Paulsen; Brenden Kunimoto; Dick Menzies
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

5.  Rifampin-resistant/multidrug-resistant Tuberculosis in Alberta, Canada: Epidemiology and treatment outcomes in a low-incidence setting.

Authors:  Brett D Edwards; Jenny Edwards; Ryan Cooper; Dennis Kunimoto; Ranjani Somayaji; Dina Fisher
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

6.  How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools.

Authors:  Leyla Asadi; Matthew Croxen; Courtney Heffernan; Mannat Dhillon; Catherine Paulsen; Mary Lou Egedahl; Greg Tyrrell; Alexander Doroshenko; Richard Long
Journal:  EClinicalMedicine       Date:  2022-01-03

7.  Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study.

Authors:  Nishta Kaushik; Chris Lowbridge; Gabriella Scandurra; Claudia C Dobler
Journal:  ERJ Open Res       Date:  2018-07-13

8.  Detailed characterisation of the tuberculosis epidemic in Western Sydney: a descriptive epidemiological study.

Authors:  Sophie Norton; Shopna K Bag; Jin-Gun Cho; Neil Heron; Hassan Assareh; Laila Pavaresh; Stephen Corbett; Ben J Marais
Journal:  ERJ Open Res       Date:  2019-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.